FR2533923B1 - - Google Patents

Info

Publication number
FR2533923B1
FR2533923B1 FR8216783A FR8216783A FR2533923B1 FR 2533923 B1 FR2533923 B1 FR 2533923B1 FR 8216783 A FR8216783 A FR 8216783A FR 8216783 A FR8216783 A FR 8216783A FR 2533923 B1 FR2533923 B1 FR 2533923B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8216783A
Other languages
French (fr)
Other versions
FR2533923A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cortial SA
Original Assignee
Cortial SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cortial SA filed Critical Cortial SA
Priority to FR8216783A priority Critical patent/FR2533923A1/fr
Priority to PT77429A priority patent/PT77429B/pt
Priority to EP83450024A priority patent/EP0105821B1/fr
Priority to DE8383450024T priority patent/DE3362332D1/de
Priority to OA58125A priority patent/OA08298A/xx
Priority to JP58185794A priority patent/JPS5988476A/ja
Priority to US06/539,285 priority patent/US4499090A/en
Priority to ES526276A priority patent/ES8405619A1/es
Priority to CA000438408A priority patent/CA1219875A/fr
Publication of FR2533923A1 publication Critical patent/FR2533923A1/fr
Application granted granted Critical
Publication of FR2533923B1 publication Critical patent/FR2533923B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/28—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR8216783A 1982-10-05 1982-10-05 Nouvelles n-(aminomethyl-5 oxazolin-2 yl-2) n'-phenylurees, leur methode de preparation ainsi que leur application therapeutique Granted FR2533923A1 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FR8216783A FR2533923A1 (fr) 1982-10-05 1982-10-05 Nouvelles n-(aminomethyl-5 oxazolin-2 yl-2) n'-phenylurees, leur methode de preparation ainsi que leur application therapeutique
PT77429A PT77429B (fr) 1982-10-05 1983-09-29 Procede pour preparer de nouvelles n-(amino-methyl-5 oxazolin-2 yl-2)n'-phenylurees et de compositions les contenant
DE8383450024T DE3362332D1 (de) 1982-10-05 1983-09-30 N-(aminomethyl-5-oxazolin-2-yl-2)-n'-phenyl ureas
EP83450024A EP0105821B1 (fr) 1982-10-05 1983-09-30 Nouvelles N-(aminométhyl-5-oxazolin-2-yl-2)N'-phénylurées
OA58125A OA08298A (fr) 1982-10-05 1983-10-03 Nouvelles N-(aminométhyl-5 oxazolin-2 yl-2) N'-phénylurées, leur méthode de préparation ainsi que leur application thérapeutique.
JP58185794A JPS5988476A (ja) 1982-10-05 1983-10-04 新規なｎ−（５−アミノメチル−２−オキサゾリン−２−イル）−ｎ′−フエニルウレア、その製法及び治療への適用
US06/539,285 US4499090A (en) 1982-10-05 1983-10-05 N-(5-aminomethyl-2-oxazolin-2-yl)-N'-phenylureas, compositions and use
ES526276A ES8405619A1 (es) 1982-10-05 1983-10-05 Procedimiento de preparacion de nuevas n-(5-aminometil 2-oxazolin 2-il)-n'-fenilureas
CA000438408A CA1219875A (fr) 1982-10-05 1983-10-05 N-(aminomethyl-5 oxazolin-2 yl-2) n'-phenylurees, leur methode de preparation ainsi que leur application therapeutique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8216783A FR2533923A1 (fr) 1982-10-05 1982-10-05 Nouvelles n-(aminomethyl-5 oxazolin-2 yl-2) n'-phenylurees, leur methode de preparation ainsi que leur application therapeutique

Publications (2)

Publication Number Publication Date
FR2533923A1 FR2533923A1 (fr) 1984-04-06
FR2533923B1 true FR2533923B1 (OSRAM) 1984-12-21

Family

ID=9278039

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8216783A Granted FR2533923A1 (fr) 1982-10-05 1982-10-05 Nouvelles n-(aminomethyl-5 oxazolin-2 yl-2) n'-phenylurees, leur methode de preparation ainsi que leur application therapeutique

Country Status (3)

Country Link
JP (1) JPS5988476A (OSRAM)
CA (1) CA1219875A (OSRAM)
FR (1) FR2533923A1 (OSRAM)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0722690Y2 (ja) * 1987-07-13 1995-05-24 三田工業株式会社 トナ−回収装置
JP6360147B2 (ja) * 2013-03-14 2018-07-18 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ グリコシダーゼ阻害剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1302662B (OSRAM) * 1971-02-04
DE1445583A1 (de) * 1960-10-13 1969-06-04 Albert Ag Chem Werke Verfahren zur Herstellung von Derivaten des 5-Chlormethyl-oxazolidins
US3481950A (en) * 1967-06-28 1969-12-02 Abbott Lab Substituted (4 - oxo-2-oxazolidinylidene) urea derivatives

Also Published As

Publication number Publication date
JPS5988476A (ja) 1984-05-22
CA1219875A (fr) 1987-03-31
FR2533923A1 (fr) 1984-04-06

Similar Documents

Publication Publication Date Title
FR2519688B1 (OSRAM)
DE3348034A1 (OSRAM)
FR2519544B1 (OSRAM)
CH655487B (OSRAM)
CH655668B (OSRAM)
FR2519567B1 (OSRAM)
DE3347867A1 (OSRAM)
DE3332129A1 (OSRAM)
DE3375853T2 (OSRAM)
CH670543GA3 (OSRAM)
CH655521B (OSRAM)
CH655565B (OSRAM)
FR2519842B3 (OSRAM)
FR2519797B1 (OSRAM)
FR2524475B1 (OSRAM)
CH655563B (OSRAM)
FR2519543B1 (OSRAM)
FR2518380B1 (OSRAM)
FR2519580B1 (OSRAM)
CH659266B (OSRAM)
DE3247369C2 (OSRAM)
FR2519553B1 (OSRAM)
FR2519872B3 (OSRAM)
FR2519557B1 (OSRAM)
FR2519891B1 (OSRAM)

Legal Events

Date Code Title Description
ST Notification of lapse